Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06575712 · ClinicalTrials.gov registry record · NA

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

A NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
177
Enrollment target
1
Study location

NCT06575712: Recruiting NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy, sponsored by Duke University.

NCT06575712 is a NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy that is actively recruiting participants, run by Duke University. The registered enrollment target is 177 participants, above the 82-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06575712, a NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
177 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to test the efficacy of a hybrid in-person and mHealth coping skills training and activity coaching intervention (Step Up), to enable HCT patients to effectively cope with symptoms (pain, fatigue, and stress) to improve their ability to engage in physical activity that can improve physical disability.

Primary Outcome

The FACT is widely used in oncology research and includes four subscales assessing physical, functional, social/family, and emotional well-being. The 7-item physical subscale will be used in this study to assess physical disability. Each item is rated on a 5-point Likert scale (0 to 4). The total score is the sum of all items and thus ranges from 0 to 28, where higher scores indicate better physical well-being.

Interventions

  • BEHAVIORAL Step Up
  • OTHER Usual Care Plus (UC+)

Study Locations (1)

North Carolina

  • Duke Cancer Institute - Durham

Trial Details

FieldValue
Enrollment Target 177 participants
Start Date 2025-04-21
Est. Completion 2028-08-31
Phase NA
Duke University

1,725 total trials

What NCT06575712 shows while recruiting

NCT06575712 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (116% higher).

The record links to 2 conditions, with Hematopoietic Stem Cell Transplant appearing as the primary indexed condition, and to 2 interventions - of which Step Up is the first listed.

NCT06575712 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06575712 about?

NCT06575712 is a clinical study titled "Coping Skills Training for Symptom Management and Daily Steps (Step Up)". The aim of this study is to test the efficacy of a hybrid in-person and mHealth coping skills training and activity coaching intervention (Step Up), to enable HCT patients to effectively cope with symptoms (pain, fatigue, and stress) to improve their ability to engage in physical activity that can i...

What is the current status of trial NCT06575712?

This trial is currently recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2025-04-21. Estimated completion is 2028-08-31.

What conditions does trial NCT06575712 study?

This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplant, CAR T-Cell Therapy.

What interventions are being tested in trial NCT06575712?

The interventions under investigation include: Step Up (BEHAVIORAL), Usual Care Plus (UC+) (OTHER).

Who is sponsoring clinical trial NCT06575712?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06575712 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic Stem Cell Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06575712's enrollment target sits among peer trials

177 2nd of 8 the highest of 8 other Hematopoietic Stem Cell Transplant trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491551 · 177 participants · NA

    Alcohol-ROC-Training

  • NCT06108050 · 177 participants · Phase 1

    JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

  • NCT06674980 · 177 participants · NA

    Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

  • NCT06719011 · 177 participants · Phase 1

    A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06575712, the US trial registry maintained by the National Library of Medicine. NCT06575712 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.